Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

New agency

- PMLiVE

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director

Innovative Trials

- PMLiVE

Mtech Access are exhibiting at ISPOR in Europe

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...

Petauri Evidence

- PMLiVE

TOMORROW: Last chance to register for FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   Wendy Erler and Alfred Samuels are ready to join Su Smith and...

Origins – The Patient Focused Specialists

- PMLiVE

Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma

Approximately 5,900 new cases of the blood cancer are diagnosed every year in the UK

- PMLiVE

Pfizer shares positive phase 3 results for Talzenna combination in prostate cancer

Up to 20% of patients will develop metastatic castration-resistant disease within five to seven years of diagnosis

- PMLiVE

Roche presents two-year data for spinal muscular atrophy treatment Evrysdi in children

The severe and progressive neuromuscular disease affects about one in every 10,000 babies

- PMLiVE

Eli Lilly and insitro collaborate to advance new treatments for metabolic diseases

Metabolic dysfunction-associated steatotic liver disease is estimated to affect 100 million people in the US

- PMLiVE

GSK’s RSV vaccine Arexvy shown to protect older adults across three seasons

The respiratory virus is estimated to impact 64 million people globally every year

- PMLiVE

Roche’s Itovebi combination granted FDA approval for advanced breast cancer

Approximately 310,720 women will be diagnosed with invasive breast cancer in the US this year

- PMLiVE

Merck and Astellas/Pfizer’s bladder cancer combination receives MHRA approval

About 614,000 people are diagnosed with bladder cancer globally every year

- PMLiVE

PM Society Awards 2025 open for entries

The ceremony will be held at JW Marriott Grosvenor House in London on 14 March

- PMLiVE

Behavioural Data Offering from Medscape Global

See more about this new insights product, Medscape AffinityTM, which offers unparalleled insights into the online behaviour of 13M+ HCPs to help you make fully informed decisions around your brand and content...

Medscape Medical Affairs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links